{"name":"Paul S. Bernstein","slug":"paul-s-bernstein","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Carotenoid Group","genericName":"Carotenoid Group","slug":"carotenoid-group","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Carotenoid Group","genericName":"Carotenoid Group","slug":"carotenoid-group","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPcEpvUDltVzY0NXlzM2RPVzM3T2hkVFJqVE05d3JkNTNHMjBSM3F6QlozZ2FsUkdsXzZENTBJdjl2MzNXbXF0SkZ4MWMxMmpQcFBMYUJlWk5sdHF5SjFQc0dZMl94YXNmUVBNMXBObk1ZckZvSE1GQnVkcV9RYVFPUXlfeWR4bUxtWHZjY0F6c1lzT3M?oc=5","date":"2025-12-26","type":"pipeline","source":"Legacy","summary":"Ellen Allin Obituary (2025) - Washington, DC - The Washington Post - Legacy","headline":"Ellen Allin Obituary (2025) - Washington, DC - The Washington Post","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTFBreVNkcENRaHhBVWQ4ZGlhUFFuUUZGdUstTmcycm5GUUVfdktqU09mNDc5Tlo3Y2ZUR2F4SU5uM3JRTTZnbE9HWWlfQ1lZV2NOQ0J5WkZEeTFpazhFcUlmRTdJckU?oc=5","date":"2025-04-22","type":"pipeline","source":"Boston Magazine","summary":"The 150 Most Influential Bostonians in 2025 - Boston Magazine","headline":"The 150 Most Influential Bostonians in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPMUxLVnJqU0t1Z3NxMk9QWDNmZ0xsZWdxY1gwajdMMlBXX21xeEJZYXlyRDRkZEFwZFdUdUpYN0w0WG9NM2pEaTJpUUNDTGVlNFhhS2Q1Y18taXItVEFRVGFMWDRKVTR3OWVybExrQnN0c240WTFOVkVYNFV6SmhJTHFQU2J3bllXT01JU0Nfcm1ZWTJ2cjFYRUtBeVBCTkdGV25KS3prUklXQlJ1Z2dSTUt4cXJzTG5KLWJmaGo3TVRGUm81N0VteWU5VGVCdHNobHJDdTExaWpzbkQtTzlLYVdrRS15UWNhV2dOY1A1LWRrVFNTMkJFcmpUeUJFWU11bzFYTW5hWQ?oc=5","date":"2024-10-01","type":"trial","source":"prnewswire.com","summary":"Kemin Highlights Groundbreaking Study on FloraGLO® Lutein and OPTISHARP™ Natural Zeaxanthin for Maternal and Infant Health - prnewswire.com","headline":"Kemin Highlights Groundbreaking Study on FloraGLO® Lutein and OPTISHARP™ Natural Zeaxanthin for Maternal and Infant Heal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPdVNKSjROSWt6S01OYVdYa1Nld25Gd2dmOHp6ZHZTbENsRmwycDhoZklnQ1k0akNIN1NXek5lTWNVNENlekhGTGZaLXVCc0xSaHI3cjVDMWoxbDhuOHBFS0hyWHlNZXZzdVplTVloNXhmdmI5YVRXenJaVUR2VjVHU0p3d1lCUlc0NmxVOXFpdHBBcE9ici1nRnItXzZlLUFmRS1nZnNR?oc=5","date":"2024-07-19","type":"pipeline","source":"Ophthalmology Times","summary":"ASRS 2024: Neurotech Pharmaceuticals update on the NT-501 device - Ophthalmology Times","headline":"ASRS 2024: Neurotech Pharmaceuticals update on the NT-501 device","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9NVS1ZQURzMnRfOTZSenBWeWdMQk5HN1FBRUR5dHpqcVdfX3I3SVQtQUtrX19TbktPYXRxOXdQQjlLc0xoQ0IteS1iY0tCX29BQXJ1Z1JLLXBOXzVuUG5PMk9obC1IZUFKX0JCaWcwQkFRLTlBVmpLVy13Qjg?oc=5","date":"2022-10-04","type":"pipeline","source":"Boston Magazine","summary":"The Boston Billionaires Club - Boston Magazine","headline":"The Boston Billionaires Club","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPaGtJVExFV2JPWm1TOGQ5Z2l1VG5udDk5RWFEMzZsVnp2Nlp5Mjc1dnFkSW1jc0Q3OGRBdUlRc052T0tIUlZ0TW42eTNqcXZOWHZBRXdoWFNGdzFzX2x0Q1dzd2VtdVNONzBEdDE2Q2FZa3p1UVc3bkt1UEJEYjIwdjZOa19td0syQlV0YjMxbm1GVGp4eElFb3hkbDZYLUpSSlRISU5jdjhldENXU0NKd05PZG1sSEw1YThUVkExdw?oc=5","date":"2018-12-10","type":"pipeline","source":"Fierce Pharma","summary":"Activist investor Elliott's latest target? A 2-way split at struggling Bayer: report - Fierce Pharma","headline":"Activist investor Elliott's latest target? A 2-way split at struggling Bayer: report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5ld0djRjhxTkt0TzlINHZmd1hMcXBfTTBjNjNpcGZ6MmZ6azFRcjZMLVNoeFF0TmxfRzdrYVJOVUpUWFQ2S2NDS04wWnh5dW02N2pwdnQ4Wm5kRWFD?oc=5","date":"2016-06-06","type":"pipeline","source":"PNAS","summary":"Photodegradation of retinal bisretinoids in mouse models and implications for macular degeneration - PNAS","headline":"Photodegradation of retinal bisretinoids in mouse models and implications for macular degeneration","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}